Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights urn:uuid:be37dc92-9110-4a82-db3f-63b2c3362614 2026-04-26T20:18:01-04:00 Jonathan Moreland Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services APLS: SULLIVAN TIMOTHY EUGENE (CFO) Disposed (JS) 11,096 Shares of APELLIS PHARMACEUTICALS INC for $0.00 on 4/17 urn:uuid:6dd3b2a7-5507-46f5-188f-ce897c370cfd 2026-04-20T16:02:06-04:00 APLS: SULLIVAN TIMOTHY EUGENE (CFO) Acquired (JB) 11,096 Shares of APELLIS PHARMACEUTICALS INC for $0.00 on 4/17 urn:uuid:4f4b1ad2-e21f-9281-393a-c5f7fe65eb14 2026-04-20T16:02:06-04:00 APLS: O BRIEN STEPHANIE MONAGHAN (DIR) Acquired (JB) 5,750 Shares of APELLIS PHARMACEUTICALS INC for $0.00 on 4/6 urn:uuid:30adf5db-595e-a004-95f7-40ff5ad9ebeb 2026-04-08T16:26:19-04:00 APLS: BIOGEN INC (O) Filed a Form 3, Becoming a Registered Insider at APELLIS PHARMACEUTICALS INC With Initial Indirect Holdings of 0 urn:uuid:2ee63146-00e4-2a3e-f75a-c48a776ac6f2 2026-04-06T18:11:26-04:00 APLS: FRANCOIS CEDRIC (CEO,DIR) Disposed (JS) 64,869 Shares of APELLIS PHARMACEUTICALS INC for $0.00 on 3/11 urn:uuid:77910d56-35fa-d4c7-f9ac-6f0cd570263c 2026-03-13T16:02:04-04:00 APLS: FRANCOIS CEDRIC (CEO,DIR) Acquired (JB) 64,869 Shares of APELLIS PHARMACEUTICALS INC for $0.00 on 3/11 urn:uuid:84fe93d7-40ee-0501-984b-91679edd0b87 2026-03-13T16:02:04-04:00 APLS: DOLSTEN MIKAEL (DIR) Acquired (JB) 14,312 Shares of APELLIS PHARMACEUTICALS INC for $0.00 on 2/27 urn:uuid:12847895-8788-77ff-22f0-40504cf6184e 2026-03-03T16:06:32-05:00 APLS: DOLSTEN MIKAEL (DIR) Filed a Form 3, Becoming a Registered Insider at APELLIS PHARMACEUTICALS INC With Initial Holdings of 0 urn:uuid:6deb2ff8-128a-5bc2-5ff1-945b2b097475 2026-03-03T16:05:37-05:00 APLS: DELONG MARK JEFFREY (O) Sold (S) 368 Shares of APELLIS PHARMACEUTICALS INC for $22.15 on 2/11 urn:uuid:986df323-78bf-8f00-b0b6-35231e0908bc 2026-02-13T09:23:44-05:00 APLS: FRANCOIS CEDRIC (CEO,DIR) Exercised 8,840 Options (OB) of APELLIS PHARMACEUTICALS INC for $3.76 on 2/3, and Kept Them All urn:uuid:b326afd7-8ee1-4b5b-3343-1f6942f9e0c3 2026-02-05T16:14:07-05:00